13. Adherence/withdrawals.
| Review | Number of trials (and participants) reporting withdrawals | Number withdrawn (per 1000) ‐ intervention group | Number withdrawn (per 1000) ‐ control group | RR or OR |
|
Bidonde 2014 (fibromyalgia) |
8 studies, n = 472 | 151 (imputed from reported 38/252) | 129 (imputed from reported 30/232) | RR 1.13 (95% CI 0.73 to 1.77) (P = 0.45) |
|
Busch 2013 (fibromyalgia) |
3 studies, n = 107 | 134 (95% CI 30 to 439) | 39 | RR 3.50 (95% CI 0.79 to 15.49) |
|
Fransen 2014 (osteoarthritis) |
7 studies, n = 715 | 59 (95% CI 30 to 114) | 34 | OR 1.77 (95% CI 0.86 to 3.65) |
|
Han 2004 (rheumatoid arthritis) |
4 studies, n = 189 | 109 (imputed from reported 11/101) | 284 (imputed from reported 25/88) | RR 0.37 (95% CI 0.19 to 0.72) |
|
Regnaux 2015 (osteoarthritis) |
1 study, n = 102 | 44 (imputed from reported 3/68 (4%); all from high‐intensity group) | 0 | Calculated RR 3.55 (95% CI 0.19 to 66.8) |
|
Saragiotto 2016 (low back pain) |
7 studies, n = 671 | 0 | 0 | ‐ |
|
Silva 2010 (rheumatoid arthritis) |
No included studies | n/a | n/a | n/a |
| Total | 30 studies, n = 2256 | 82.8/1000 | 81/1000 |
Calculated RR 1.02 (95% CI 0.94 to 1.12) Calculated OR 1.05 (95% CI 0.88 to 1.25) |
CI: confidence interval; n: number of participants; n/a: not applicable; OR: odds ratio; RR: risk ratio.